Global Sleep Disorder Market 2026–2030: Forecast Insights for Business Planning

Uncover key drivers, emerging technologies, and competitive movements shaping the sleep disorder market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Sleep Disorder Market?

The sleep disorder market size has experienced significant growth in recent years. This market is expected to increase from $33.32 billion in 2025 to $38.23 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.7%. Factors contributing to its historical growth include greater awareness of sleep health, an increase in the prevalence of insomnia and sleep apnea, wider adoption of sleep diagnostic services, a growing geriatric population, escalating stress and lifestyle-induced sleep issues, and the rising utilization of smartphones and wearable devices for sleep tracking.

The sleep disorder market is projected for significant expansion in the coming years. This market is anticipated to reach $65.51 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 14.4%. This projected growth is primarily driven by factors such as the increasing availability of telemedicine for sleep disorders, the growing use of wearable sleep trackers, the rise in at-home diagnostic testing, the development of cognitive behavioral therapy applications, and enhanced government efforts to promote sleep health awareness. Key trends expected during this period involve improvements in wearable sleep monitoring devices, progress in home-based sleep diagnostic tools, developments in AI-powered sleep analysis, novel non-invasive treatments for sleep apnea, new approaches in telemedicine for sleep consultations, and advancements in cognitive behavioral therapy applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30744&type=smp

Which Drivers Are Supporting The Rise Of The Sleep Disorder Market?

Future expansion in the sleep disorder market is anticipated, driven by escalating levels of stress and anxiety. These levels denote the extent of psychological stress and excessive concern present among people, frequently stemming from environmental, societal, or economic factors. A rise in stress and anxiety is observed, particularly fueled by work-related demands such as increased workloads, stringent deadlines, and employment uncertainty for workers. Elevated stress and anxiety contribute to sleep disorders by interfering with regular sleep cycles and making it harder to initiate or maintain sleep. This, in turn, deteriorates overall health by hindering restorative sleep, which can result in tiredness, reduced cognitive function, and an elevated susceptibility to long-term illnesses. As an illustration, figures from May 2024 by the American Psychiatric Association (APA), a professional body in the U.S., indicated that 43% of U.S. adults reported higher anxiety levels in 2024 compared to the prior year, marking an increase from 37% in 2023 and 32% in 2022. Consequently, the expanding presence of stress and anxiety is propelling the expansion of the sleep disorder market.

What Segments Are Identified Within The Structure Of The Sleep Disorder Market?

The sleep disorder market covered in this report is segmented –

1) By Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Circadian Rhythm Disorders

2) By Treatment: Cognitive Behavioral Therapy, Medication Therapy, Psychiatric Treatment, Behavioral Treatment

3) By Diagnostic Method: Polysomnography, Home Sleep Testing, Actigraphy, Sleep Diaries, Questionnaires and Screening

4) By Distribution Channel: Retail Pharmacies, Online Sales, Hospital Pharmacies

5) By End-User: Hospitals And Sleep Centers, Home Care Settings, Academic

Subsegments:

1) By Insomnia: Acute Insomnia, Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia, Medication-Induced Insomnia

2) By Sleep Apnea: Obstructive Sleep Apnea, Central Sleep Apnea, Complex Sleep Apnea Syndrome, Mild Sleep Apnea, Moderate Sleep Apnea, Severe Sleep Apnea, Pediatric Sleep Apnea, Treatment-Resistant Sleep Apnea

3) By Restless Legs Syndrome: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome, Mild Restless Legs Syndrome, Moderate Restless Legs Syndrome, Severe Restless Legs Syndrome, Intermittent Restless Legs Syndrome, Chronic Persistent Restless Legs Syndrome

4) By Narcolepsy: Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia, Pediatric Narcolepsy, Treatment-Resistant Narcolepsy, Secondary Narcolepsy

5) By Circadian Rhythm Disorders: Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Shift Work Sleep Disorder, Jet Lag Disorder, Irregular Sleep-Wake Rhythm Disorder, Non-24-Hour Sleep-Wake Disorder

What Trends Are Projected To Support The Growth Of The Sleep Disorder Market?

Leading companies within the sleep disorder market are concentrating on developing sophisticated therapeutic technologies, such as electrical vestibular nerve stimulation (VeNS) methods. These innovations aim to offer non-pharmacological treatment alternatives, thereby improving sleep quality, normalizing circadian rhythms, and assisting individuals suffering from chronic insomnia. The electrical vestibular nerve stimulation (VeNS) method is characterized as a non-invasive therapeutic technique that works by sending low-level electrical pulses to the vestibular nerve, a critical neural pathway, to affect brain areas responsible for sleep regulation, all without requiring surgical intervention or medication. A notable example is Neurovalens Ltd., a health-tech company based in the UK, which introduced Modius Sleep in October 2024. This FDA-cleared, non-invasive device specifically addresses chronic insomnia through the application of electrical vestibular nerve stimulation (VeNS). This medical device, styled as a headset, is intended for use for approximately 30 minutes every evening. It transmits safe electrical pulses to the vestibular nerve, which in turn influences the hypothalamus and brainstem regions that manage circadian rhythm and sleep patterns, ultimately enabling users to achieve sleep more rapidly and sustain it for longer durations.

Which Key Players Are Driving Competition In The Sleep Disorder Market?

Major companies operating in the sleep disorder market are Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Biogen Inc., Union Chimique Belge S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Neurocrine Biosciences Inc., Harmony Biosciences Holdings Inc., Vanda Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sleep-disorder-market-report

Which Region Is Projected To Lead The Sleep Disorder Market During The Forecast Period?

North America was the largest region in the sleep disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleep disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sleep Disorder Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30744&type=smp

Browse Through More Reports Similar to the Global Sleep Disorder Market 2026, By The Business Research Company

Insomnia Market Report 2026

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

sleep testing services global market report

https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795